|
Quotes & Info
|
| IPXL > SEC Filings for IPXL > Form 8-K on 8-Jan-2013 | All Recent SEC Filings |
8-Jan-2013
Regulation FD Disclosure, Financial Statements and Exhibits
On Monday, January 7, 2013, Impax Laboratories, Inc. (the "Company") is scheduled to present at the 31st Annual J.P. Morgan Healthcare Conference. A copy of the materials that the Company will present at the conference is attached hereto as Exhibit 99.1 and incorporated herein by reference.
This Current Report on Form 8-K and the information in this Item 7.01 hereof will not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor will it be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act unless expressly identified therein as being specifically incorporated therein by reference.
(d) Exhibits.
The following exhibit is furnished herewith.
Exhibit No. Description
99.1 31st Annual J.P. Morgan Healthcare Conference Presentation dated as
of January 7, 2013.
|
|
|